Glucose | Blood Sugar Tracker vs its rivals

Side-by-side comparison against Glucose | Blood Sugar Tracker's closest competitors — identity, store metrics, ratings & sentiment, and strategic intel.

Core Identity
DeveloperApp Sub 1 LLCmySugr GmbHAbbott LabsAzumio Inc.Evolve Medical Systems, LLCMediSafe Inc.Voluntis
CategoryMedicalMedicalMedicalMedicalMedicalMedicalMedical
PlatformiOS, AndroidiOS, AndroidiOS, AndroidiOS, AndroidiOS, AndroidiOSiOS, Android
Store Metrics
Rating4.6 / 54.7 / 54.6 / 54.8 / 54.5 / 54.7 / 54.8 / 5
Ratings Count28,09130,731105,45924,57855,60799,62639,656
PriceFreeFreeFreeFreeFreeFreeFree
Release DateJul 18, 2016Jun 3, 2013Mar 31, 2025Oct 28, 2008Jun 28, 2012Nov 8, 2012Mar 27, 2015
Last UpdatedMar 2, 2026Apr 12, 2026Jan 16, 2026Apr 26, 2026Apr 15, 2026Feb 10, 2026Apr 14, 2026
Sentiment & Reviews
Sentimentnegative-mixedterrible-terrible-
Score25/100-45/10015/100-25/100-
Praises
  • Estimated A1C tracking provides valuable health insights for long-term diabetic management
-
  • Real-time glucose monitoring provides freedom from manual finger-prick testing throughout the day
  • Comprehensive health tracking features allow users to monitor glucose and blood pressure effectively
-
  • Reliable medication reminders provide essential daily support for managing complex health schedules
-
Complaints
  • Frequent application crashes during startup or data synchronization break the daily logging habit
  • Misleading marketing regarding automatic blood glucose monitoring capabilities causes significant user frustration
-
  • Frequent Bluetooth connection drops between the sensor and mobile device disrupt continuous data tracking
  • Persistent application crashes and loading failures prevent access to critical health data
  • Aggressive subscription prompts and paywalls frustrate users attempting to access basic functionality
-
  • Frequent application crashes and interface freezes prevent users from logging medication doses
  • Aggressive transition to a paid subscription model locks users out of existing data
-
Requests
  • Direct integration with wearable glucose monitors to eliminate the need for manual data entry
-
  • Integration with Apple Health is requested to centralize glucose data with other health metrics
  • Seamless integration with third-party health platforms for data synchronization and backup
---
Strategic Intel
Strengths
  • Clinical reporting exports increase switching costs for users
  • A1C estimation provides long-term health value
  • HealthKit sync reduces data entry friction
-
  • Proprietary sensor-hardware integration creates high switching costs
  • LibreView clinical data management drives provider-led prescription volume
  • 15-year market presence builds significant trust
  • Direct hardware integration creates high switching costs
-
  • Clinical-grade drug interaction engine
  • Deep integration with US health infrastructure
  • Multi-user family sync
-
Weaknesses
  • Frequent startup crashes break daily logging habits
  • Manual entry requirement contradicts marketing
  • Aggressive subscription paywalls drive refund requests
-
  • Frequent Bluetooth connection drops
  • Lack of Apple Health data syncing
  • 0.7★ Android-iOS rating gap
  • 2.25★ Android rating vs 4.8★ iOS rating
  • Persistent launch-time crashes on latest versions
  • Unresponsive customer support for billing issues
-
  • High crash frequency post-update
  • Mandatory paywall for historical data
  • Inconsistent notification reliability
-
Pricingfreefreemiumfreesubscriptionfreefreemiumfreemium
MomentumActiveIntense-MaintenanceIntenseActiveIntense
Update Cadence5 versions5 versions-3 versions, ~325d avg5 versions5 versions, ~11d avg5 versions

Compare Glucose | Blood Sugar Tracker head-to-head

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Glucose | Blood Sugar Tracker, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Data licensed under CC-BY-NC 4.0